Explore 3 Stock Ideas & Industry Insights Download Free Report

Corbion NV ADR

Basic Materials US CSNVY

23.5USD
1.25(5.62%)

Last update at 2026-06-22T16:28:00Z

Day Range

23.5023.50
LowHigh

52 Week Range

19.8125.50
LowHigh

Fundamentals

  • Previous Close 22.25
  • Market Cap1352.56M
  • Volume900
  • P/E Ratio15.33
  • Dividend Yield3.18%
  • EBITDA187.50M
  • Revenue TTM1267.40M
  • Revenue Per Share TTM21.86
  • Gross Profit TTM 334.70M
  • Diluted EPS TTM1.49

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 91.15M 62.50M 85.30M 116.40M 86.50M
Minority interest 0.00000M 0.00000M - - -
Net income 71.85M 192.20M 72.90M 90.00M 78.30M
Selling general administrative 171.00M 113.30M 103.20M 92.40M 85.50M
Selling and marketing expenses - 74.30M 74.10M 81.10M 67.50M
Gross profit 317.26M 312.10M 352.70M 324.30M 265.80M
Reconciled depreciation 85.80M 86.80M 84.60M 76.40M 64.10M
Ebit 111.90M 85.20M 115.80M 110.80M 65.00M
Ebitda 194.32M 172.00M 198.00M 200.30M 129.10M
Depreciation and amortization 82.41M 86.80M 82.20M 89.50M 64.10M
Non operating income net other - - - - -
Operating income 111.90M 77.30M 77.30M 110.80M 65.00M
Other operating expenses 1105.48M 1210.80M 1186.80M 1354.30M 1023.80M
Interest expense 21.23M 22.70M 29.70M 17.00M 13.70M
Tax provision 20.10M 16.60M 12.40M 26.40M 8.20M
Interest income 4.60M 11.50M 6.40M 3.40M 4.40M
Net interest income -17.50000M -11.20000M -24.40000M -14.40000M -8.90000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 19.31M 16.60M 12.40M 26.40M 8.20M
Total revenue 1217.38M 1288.10M 1443.80M 1457.90M 1070.80M
Total operating expenses 205.36M 234.80M 228.10M 220.70M 218.80M
Cost of revenue 900.12M 976.00M 1091.10M 1133.60M 805.00M
Total other income expense net -20.74751M -14.80000M -31.90000M 5.60M 21.50M
Discontinued operations - - - - -
Net income from continuing ops 74.80M 45.90M 72.90M 90.00M 78.30M
Net income applicable to common shares - - - 90.00M 78.30M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1416.30M 1546.30M 1699.70M 1705.40M 1341.10M
Intangible assets 60.37M 68.90M 75.10M 80.10M 80.20M
Earning assets - - - - -
Other current assets 69.17M 2.10M 45.70M - 232.30M
Total liab 674.01M 773.80M 1063.50M 1079.70M 787.00M
Total stockholder equity 742.28M 772.50M 636.20M 625.70M 554.10M
Deferred long term liab - - - - 30.70M
Other current liab 98.22M 129.40M 110.50M 122.40M 108.40M
Common stock 14.79M 14.80M 14.80M 14.80M 14.80M
Capital stock 14.80M 14.80M 14.80M 14.80M 14.80M
Retained earnings 706.30M 675.80M 540.60M 493.80M 430.20M
Other liab - - - 49.80M 47.40M
Good will 28.69M 30.10M 81.30M 83.50M 77.70M
Other assets - - -12.90000M - 142.10M
Cash 44.68M 49.30M 70.20M 58.20M 42.20M
Cash and equivalents - - - - -
Total current liabilities 306.47M 438.00M 588.30M 592.70M 321.00M
Current deferred revenue - - 2.50M - -
Net debt 401.92M 459.90M 715.30M 701.00M 461.00M
Short term debt 99.00M 201.30M 368.50M 322.00M 84.60M
Short long term debt 86.60M 188.00M 356.00M 309.70M 74.70M
Short long term debt total 446.60M 509.20M 785.50M 759.20M 503.20M
Other stockholder equity 55.18M 81.90M 55.20M 117.10M 109.10M
Property plant equipment - - - 729.50M 532.90M
Total current assets 579.75M 513.00M 579.70M 654.30M 504.50M
Long term investments - - - - -
Net tangible assets - - - - 426.90M
Short term investments - - 61.90M - -
Net receivables 224.80M 203.50M 200.90M 210.50M 212.40M
Long term debt 313.10M 262.20M 364.60M 376.00M 359.10M
Inventory 241.10M 258.10M 262.90M 331.20M 230.00M
Accounts payable 109.25M 105.30M 104.30M 148.30M 128.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -33.98553M - 25.60M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.10M 99.30M 49.60M 127.40M 118.50M
Deferred long term asset charges - - - - -
Non current assets total 836.54M 1033.30M 1120.00M 1051.10M 836.60M
Capital lease obligations 46.90M 59.00M 64.90M 73.50M 69.40M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -1.90000M 166.00M -146.80000M -199.10000M 5.50M
Change to liabilities - - - 14.60M 25.70M
Total cashflows from investing activities -67.33334M 166.00M -146.80000M -199.10000M -119.40000M
Net borrowings -33.30000M -296.20000M 41.20M 221.80M 118.90M
Total cash from financing activities -90.09797M -371.70000M -5.30000M 173.90M 85.90M
Change to operating activities - - - - -17.90000M
Net income 71.85M 281.80M 72.90M 110.80M 82.00M
Change in cash 1.23M -20.90000M 12.00M 16.00M -9.40000M
Begin period cash flow 43.45M 70.20M 58.20M 42.20M 51.60M
End period cash flow 44.68M 49.30M 70.20M 58.20M 42.20M
Total cash from operating activities 154.55M 184.10M 165.40M 39.00M 22.40M
Issuance of capital stock - - - - -
Depreciation 82.41M 86.80M 84.60M 76.40M 64.10M
Other cashflows from investing activities - 251.80M 4.60M 14.20M 4.30M
Dividends paid 35.73M 41.90M 33.10M -33.00000M -33.00000M
Change to inventory -0.67237M -5.20000M 61.50M -90.40000M -54.40000M
Change to account receivables -13.63956M 6.20M 4.70M -39.00000M -33.20000M
Sale purchase of stock -9.60533M -20.00000M - - -
Other cashflows from financing activities -12.77509M -13.60000M -13.40000M 209.60M 121.80M
Change to netincome - - - - -40.20000M
Capital expenditures 65.51M 84.20M 149.30M 235.80M 148.70M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -21.70804M 37.90M 13.60M -110.10000M -86.20000M
Stock based compensation 5.20M 4.70M 4.10M 4.80M 3.50M
Other non cash items 22.00M -227.10000M 134.40M -42.90000M -11.80000M
Free cash flow 89.04M 99.90M 16.10M -196.80000M -126.30000M

Peer Comparison

Sector: Basic Materials Industry: Specialty Chemicals

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CSNVY
Corbion NV ADR
1.25 5.62% 23.50 15.33 12.66 1.07 1.43 1.19 7.66
LIN
Linde plc Ordinary Shares
4.56 0.89% 516.71 33.77 28.90 6.56 5.42 7.03 18.92
AIQUY
Air Liquide SA ADR
-0.61 1.59% 37.81 30.69 24.81 4.70 4.10 4.36 15.61
AIQUF
L'Air Liquide S.A
0.0013 0.0007% 190.41 30.66 24.51 4.69 4.05 4.36 15.61
SHW
Sherwin-Williams Co
-3.89 1.21% 316.90 33.33 27.40 3.38 20.60 3.88 21.36

Reports Covered

Stock Research & News

Profile

Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing product; AlgaVia which develops foods and beverages with reduced saturated fat content; CALFEED, a dry lactic acid source to boost feed intake for swine or poultry; LAFEED that helps feed intake and digestive health; LAFEED Powder that acts as a preservative and acidulate; PURAC DW, provides an acidifier, preservative, and antimicrobial in teat-dip applications for animals; PURAC Pet food; PURASOLV; and PURASOLV EL. It also provides PURASORB polymers for medical and pharmaceutical industries; PURASOLV solvents; PURALACT B3 for resin and coating performance; personal care products, such as ESTERLAC Emulsifiers and Surfactants, GLUCONAL ZN, PURAC BF/P41, PURAC HiPure 90, PURAC UltraPure, PURACAL PP/USP, PURAMEX ZN, PURASAL MOISTXS, PURASAL NH/COS, PURASAL S/HQ60, and PURASOLV EL; and GLUCONAL, PURAC PF, PURACAL, PURAMEX, and PURASAL S/PF. In addition, the company offers food solutions, including acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning and texturizing, and taste and texture; PURASORB R&D; biochemical specialties solutions comprising solvency, antimicrobial, moisturization, and pharma; and Algae ingredients solutions. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1903 and is headquartered in Amsterdam, the Netherlands.

Corbion NV ADR

Piet Heinkade 127, Amsterdam, Netherlands, 1019 GM

Key Executives

Name Title Year Born
Mr. Olivier Rigaud Chairman of the Management Board & CEO 1964
Mr. Eddy Van Rhede van Der Kloot CFO & Member of Management Board 1963
Ms. Jacqueline van Lemmen Chief Operations Officer 1961
Mr. Marcel Wubbolts Chief Science & Sustainability Officer 1963
Jeroen van Harten Director of Investor Relations NA
Tanno Massar Director of Corp. Communications NA
Ms. Aurelie Dalbiez Chief HR Officer 1977
Mr. Andy Muller Pres of Sustainable Food Solutions 1965
Mr. Ruud Peerbooms Pres of Algae Ingredients 1969
Mr. Marco Bootz Pres of Lactic Acid & Specialties 1972

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions